Form 3 Eloxx Pharmaceuticals, For: Apr 27 Filed by: Coastlands Capital LP
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||||||
1. Name and Address of Reporting Person
*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 04/27/2026 |
3. Issuer Name
and
Ticker or Trading Symbol
Eloxx Pharmaceuticals, Inc. [ ELOX ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check
Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 1,250,000 | By Coastlands Capital LP (1) | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Pre-funded Warrant | (2) | (2) | Common Stock | 29,362,243 | 0.01 | I | By Coastlands Capital LP (1) |
| /s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital LP | 05/01/2026 | |
| ** Signature of Reporting Person | Date | |
| /s/ Mark Shamia, Chief Operating Officer of the General Partner of Coastlands Capital Partners LP | 05/01/2026 | |
| ** Signature of Reporting Person | Date | |
| /s/ Mark Shamia, Chief Operating Officer of Coastlands Capital GP LLC | 05/01/2026 | |
| ** Signature of Reporting Person | Date | |
| /s/ Mark Shamia, Chief Operating Officer of Coastlands Capital LLC | 05/01/2026 | |
| ** Signature of Reporting Person | Date | |
| /s/ Matthew D. Perry | 05/01/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
ATTACHMENTS / EXHIBITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ganfeng LiEnergy Debuts at Intersolar Europe 2026, Building a Full-Chain Energy Storage Operations and Service System
- Longtime Offshore-Energy Investor Robotti & Company Calls on McDermott Board to Let All Shareholders Participate Equally in Rights Offering
- iQIYI International Releases First Half of 2026 Global Trending Content: Chinese Dramas and Micro Dramas Power Dual-Engine Global Growth
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share